Victory Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$226M Sell
642,962
-494,351
-43% -$176M 0.14% 176
2025
Q4
$372M Buy
1,137,313
+475,799
+72% +$151M 0.21% 102
2025
Q3
$187M Sell
661,514
-354,439
-35% -$103M 0.11% 180
2025
Q2
$284M Buy
1,015,953
+65,060
+7% +$18.4M 0.18% 129
2025
Q1
$296M Buy
950,893
+126,602
+15% +$37.4M 0.3% 71
2024
Q4
$215M Buy
824,291
+107,374
+15% +$31.9M 0.21% 105
2024
Q3
$231M Sell
716,917
-9,613
-1% -$3.14M 0.22% 99
2024
Q2
$227M Sell
726,530
-8,853
-1% -$2.6M 0.23% 101
2024
Q1
$209M Sell
735,383
-127,631
-15% -$37.3M 0.2% 113
2023
Q4
$249M Sell
863,014
-112,730
-12% -$30.7M 0.26% 93
2023
Q3
$262M Sell
975,744
-45,216
-4% -$11.3M 0.3% 80
2023
Q2
$227M Sell
1,020,960
-134,572
-12% -$31.2M 0.25% 96
2023
Q1
$279M Sell
1,155,532
-27,879
-2% -$6.84M 0.31% 74
2022
Q4
$311M Sell
1,183,411
-10,674
-0.9% -$2.86M 0.36% 60
2022
Q3
$269M Buy
1,194,085
+104,465
+10% +$25.3M 0.31% 64
2022
Q2
$265M Buy
1,089,620
+6,492
+0.6% +$1.59M 0.3% 63
2022
Q1
$254M Buy
1,083,128
+35,130
+3% +$8.07M 0.25% 85
2021
Q4
$236M Buy
1,047,998
+71,519
+7% +$15.1M 0.22% 106
2021
Q3
$208M Buy
976,479
+106,023
+12% +$24.4M 0.2% 113
2021
Q2
$212M Buy
870,456
+74,326
+9% +$18.3M 0.2% 116
2021
Q1
$198M Sell
796,130
-11,515
-1% -$2.75M 0.2% 113
2020
Q4
$186M Sell
807,645
-69,866
-8% -$16.1M 0.21% 102
2020
Q3
$223M Buy
877,511
+43,483
+5% +$10.8M 0.29% 57
2020
Q2
$197M Sell
834,028
-798,080
-49% -$182M 0.27% 74
2020
Q1
$331M Buy
1,632,108
+653,980
+67% +$143M 0.28% 71
2019
Q4
$236M Sell
978,128
-38,168
-4% -$8.41M 0.29% 65
2019
Q3
$197M Buy
1,016,296
+812,881
+400% +$156M 0.25% 87
2019
Q2
$37.5M Buy
203,415
+117,023
+135% +$21M 0.08% 399
2019
Q1
$16.4M Buy
86,392
+73,949
+594% +$14.1M 0.04% 612
2018
Q4
$2.42M Buy
12,443
+190
+2% +$37.1K 0.01% 990
2018
Q3
$2.54M Sell
12,253
-803
-6% -$158K 0.01% 1056
2018
Q2
$2.41M Buy
13,056
+39
+0.3% +$6.9K 0.01% 1037
2018
Q1
$2.22M Sell
13,017
-12,932
-50% -$2.37M ﹤0.01% 1044
2017
Q4
$4.51M Sell
25,949
-203
-0.8% -$35.9K 0.01% 829
2017
Q3
$4.88M Buy
26,152
+1,475
+6% +$261K 0.01% 815
2017
Q2
$4.25M Buy
24,677
+1,191
+5% +$194K 0.01% 829
2017
Q1
$3.85M Sell
23,486
-1,561
-6% -$259K 0.01% 848
2016
Q4
$3.66M Buy
25,047
+1,521
+6% +$229K 0.01% 831
2016
Q3
$3.92M Buy
23,526
+8,321
+55% +$1.41M 0.01% 795
2016
Q2
$2.31M Sell
15,205
-77
-0.5% -$12K 0.01% 669
2016
Q1
$2.29M Buy
15,282
+199
+1% +$29.6K 0.01% 674
2015
Q4
$2.45M Buy
15,083
+11,188
+287% +$1.76M 0.01% 638
2015
Q3
$539K Sell
3,895
-32
-0.8% -$5.04K ﹤0.01% 968
2015
Q2
$607K Buy
+3,927
New +$629K ﹤0.01% 953
2013
Q4
Sell
-192
Closed -$21K 927
2013
Q3
$21K Buy
+192
New +$20.8K ﹤0.01% 936

Other funds holding AMGN

Victory Capital Management's AMGN Position: Q1 2026 in Review

Victory Capital Management reduced its Amgen (AMGN) stake by 43% in Q1 2026, selling an estimated $176M and leaving 642,962 shares worth $226M. The position accounts for 0.14% of the portfolio, ranked #176.

Victory Capital Management first reported a position in AMGN in Q3 2013 and has held it in 45 quarters since. The position peaked at $372M in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Victory Capital Management held 642,962 shares of Amgen worth $226M as of Q1 2026.
  • Victory Capital Management sold 494,351 Amgen shares in Q1 2026, an estimated $176M.
  • Amgen made up 0.14% of Victory Capital Management's portfolio in Q1 2026, its #176 holding.
  • Victory Capital Management first reported a position in Amgen in Q3 2013 and has held it in 45 quarters since.
  • Victory Capital Management's Amgen position peaked at $372M in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.